155 related articles for article (PubMed ID: 16436301)
1. Depression with above-normal plasma vasopressin: validation by relations with family history of depression and mixed anxiety and retardation.
Goekoop JG; de Winter RP; de Rijk R; Zwinderman KH; Frankhuijzen-Sierevogel A; Wiegant VM
Psychiatry Res; 2006 Feb; 141(2):201-11. PubMed ID: 16436301
[TBL] [Abstract][Full Text] [Related]
2. Anxious-retarded depression: relation to family history of depression.
de Winter RF; Zwinderman KH; Goekoop JG
Psychiatry Res; 2004 Jun; 127(1-2):111-9. PubMed ID: 15261710
[TBL] [Abstract][Full Text] [Related]
3. Anxious-retarded depression: relation to two-year outcome of major depressive disorder.
de Winter RF; Zitman FG; van Houwelingen JC; Wolterbeek R; Goekoop JG
J Affect Disord; 2006 Jan; 90(1):77-81. PubMed ID: 16325260
[TBL] [Abstract][Full Text] [Related]
4. Evidence of vasopressinergic-noradrenergic mechanisms in depression with above-normal plasma vasopressin concentration with and without psychotic features.
Goekoop JG; de Winter RF; Wolterbeek R; van Kempen GM; Wiegant VM
J Psychopharmacol; 2011 Mar; 25(3):345-52. PubMed ID: 19942636
[TBL] [Abstract][Full Text] [Related]
5. Anxious-retarded depression: relation with plasma vasopressin and cortisol.
de Winter RF; van Hemert AM; DeRijk RH; Zwinderman KH; Frankhuijzen-Sierevogel AC; Wiegant VM; Goekoop JG
Neuropsychopharmacology; 2003 Jan; 28(1):140-7. PubMed ID: 12496950
[TBL] [Abstract][Full Text] [Related]
6. Character and temperament in major depressive disorder and a highly anxious-retarded subtype derived from melancholia.
de Winter RF; Wolterbeek R; Spinhoven P; Zitman FG; Goekoop JG
Compr Psychiatry; 2007; 48(5):426-35. PubMed ID: 17707250
[TBL] [Abstract][Full Text] [Related]
7. Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression.
Young EA; Abelson JL; Cameron OG
Biol Psychiatry; 2004 Jul; 56(2):113-20. PubMed ID: 15231443
[TBL] [Abstract][Full Text] [Related]
8. Dimensions of depression and anxiety and the hypothalamo-pituitary-adrenal axis.
Wardenaar KJ; Vreeburg SA; van Veen T; Giltay EJ; Veen G; Penninx BW; Zitman FG
Biol Psychiatry; 2011 Feb; 69(4):366-73. PubMed ID: 21030010
[TBL] [Abstract][Full Text] [Related]
9. [A multidimensional description and validation of two subtypes in the field of endogenous and melancholic depression].
Goekoop JG
Tijdschr Psychiatr; 2008; 50(3):159-70. PubMed ID: 18383629
[TBL] [Abstract][Full Text] [Related]
10. Bipolar II and anxious reactive "comorbidity": toward better phenotypic characterization suitable for genotyping.
Akiskal HS; Akiskal KK; Perugi G; Toni C; Ruffolo G; Tusini G
J Affect Disord; 2006 Dec; 96(3):239-47. PubMed ID: 16973219
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin-neurophysin and DST in major depression: relationship with suicidal behavior.
Pitchot W; Scantamburlo G; Pinto E; Hansenne M; Reggers J; Ansseau M; Legros JJ
J Psychiatr Res; 2008 Jul; 42(8):684-8. PubMed ID: 17720191
[TBL] [Abstract][Full Text] [Related]
12. Interaction of brain noradrenergic system and the hypothalamic-pituitary-adrenal (HPA) axis in man.
Young EA; Abelson JL; Cameron OG
Psychoneuroendocrinology; 2005 Sep; 30(8):807-14. PubMed ID: 15896919
[TBL] [Abstract][Full Text] [Related]
13. Support for two increased vasopressinergic activities in depression at large and the differential effect of antidepressant treatment.
Goekoop J; de Winter R; Wolterbeek R; Wiegant V
J Psychopharmacol; 2011 Oct; 25(10):1304-12. PubMed ID: 20624797
[TBL] [Abstract][Full Text] [Related]
14. [Neurobiology and genetics of anxiety in an animal model].
Landgraf R
Nervenarzt; 2003 Mar; 74(3):274-8. PubMed ID: 12627244
[TBL] [Abstract][Full Text] [Related]
15. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
Connan F; Lightman SL; Landau S; Wheeler M; Treasure J; Campbell IC
J Psychiatr Res; 2007; 41(1-2):131-43. PubMed ID: 16455105
[TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety.
Keck ME
Amino Acids; 2006 Oct; 31(3):241-50. PubMed ID: 16733617
[TBL] [Abstract][Full Text] [Related]
17. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder.
Soygur H; Palaoglu O; Akarsu ES; Cankurtaran ES; Ozalp E; Turhan L; Ayhan IH
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1242-7. PubMed ID: 17587477
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to depression expressed as alterations in cortisol day curve: a cross-twin, cross-trait study.
Wichers MC; Myin-Germeys I; Jacobs N; Kenis G; Derom C; Vlietinck R; Delespaul P; Mengelers R; Peeters F; Nicolson N; Van Os J
Psychosom Med; 2008 Apr; 70(3):314-8. PubMed ID: 18378863
[TBL] [Abstract][Full Text] [Related]
20. The counterbalance between leptin and cortisol may be associated with comorbid depression and anxiety.
Liao SC; Lee MB; Lee YJ; Huang TS
Psychiatry Clin Neurosci; 2006 Feb; 60(1):120. PubMed ID: 16472372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
